Search
Brainsway Ltd
BWAYAdd to Watchlist
14.400USD
+0.010+0.07%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
586.27MMarket Cap
31.40P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-24The current earnings forecast score of Brainsway Ltd is 8.67, ranking 17 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 23.50, with a high of 24.00 and a low of 23.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
16.667
Target Price
+11.93%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
4
Median
6
Average
Company name
Ratings
Analysts
Brainsway Ltd
BWAY
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Brainsway Ltd's expected revenue for the next quarter?
Brainsway Ltd's expected revenue is 16.31M.
What is Brainsway Ltd's price target?
Analysts forecast that Brainsway Ltd's price target is USD 23.50, with the highest forecast at USD 24.00 and the lowest forecast at USD 23.00.
How have Brainsway LtdBWAY's recent earnings per share performed?
The market expectation was USD 0.12, while Brainsway LtdBWAY's earnings per share (EPS) for the previous quarter was USD 0.17. EPS for the next quarter is expected at USD 0.06.
What is the analyst rating for Brainsway Ltd?
Based on the ratings of Brainsway Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
